Abstract
Foot complications associated with diabetes are the most common cause of non-traumatic lower-extremity amputations in the industrialised countries. Revascularisation techniques require precise preoperative imaging. Magnetic resonance angiography (MRA) using gadofosveset trisodium (Vasovist, Bayer Schering Pharma AG, Berlin, Germany) has the potential to detect significantly more patent pedal vessel segments than selective digital substractive angiography (DSA) in an examination with two blinded readers. MRI and MRA are the imaging methods of choice for differentiated assessment of the diabetic foot and its complications, and they are robust techniques for delineating the pedal macrocirculation. Therefore, they should play a central role in the management of patients with a diabetic foot syndrome.
Similar content being viewed by others
References
Armstrong DG, Lavery LA (1998) Diabetic foot ulcers: prevention, diagnosis and classification. Am Fam Physician 15:1325–1332
Pomposelli FB Jr, Marcaccio EJ, Gibbons GW, et al. (1995) Dorsalis pedis arterial bypass: durable limb salvage for foot ischemia in patients with diabetes mellitus. J Vasc Surg 21:375–384
Kreitner K-F, Kalden P, Neufang A, et al. (2000) Diabetes and peripheral arterial occlusive disease: prospective comparison of contrast-enhanced three-dimensional MR angiography with conventional digital subtraction angiography. AJR Amer J Roentgenol 174:171–179
Hofmann WJ, Forstner R, Kofler B, Binder K, Ugurluoglu A, Magometschnigg H (2002) Pedal artery imaging - a comparison of selective digital subtraction angiography, contrast enhanced magnetic resonance angiography and duplex ultrasound. Eur J Endovasc Surg 24:287–292
Cronberg CN, Sjöberg S, Albrechtsson U, et al. (2003) Peripheral arterial disease. Contrast-enhanced 3D MR angiography of the lower leg and foot compared with conventional angiography. Acta Radiol 44:59–66
Kreitner K-F, Kunz RP, Herber S, Martenstein S, Dorweiler B, Dueber C (2008) MR angiography of the pedal arteries with gadobenate dimeglumine, a contrast agent with increased relaxivity, and comparison with selective intraarterial DSA. J Magn Reson Imaging 27:78–85
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kreitner, KF., Roehrl, B., Weber, S. et al. MRA of the foot with a blood pool agent. Eur Radiol Suppl 18 (Suppl 5), 21–25 (2008). https://doi.org/10.1007/s10406-009-0242-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10406-009-0242-8